Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125060092 | 12506009 | 2 | F | 20160119 | 20160809 | 20160628 | 20160817 | EXP | JP-MYLANLABS-2016M1025832 | MYLAN | 0.00 | Y | 0.00000 | 20160817 | MD | COUNTRY NOT SPECIFIED | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125060092 | 12506009 | 1 | PS | Carboplatin MYLAN | CARBOPLATIN | 1 | Intravenous drip | 450 MG, CYCLE | 91063 | 450 | MG | INJECTION | |||||||
| 125060092 | 12506009 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous drip | 143 MG, CYCLE | 0 | 143 | MG | INJECTION | |||||||
| 125060092 | 12506009 | 3 | C | EMEND | APREPITANT | 1 | Unknown | 125 ??, ?? | 0 | CAPSULE | |||||||||
| 125060092 | 12506009 | 4 | C | ALOXI | PALONOSETRON HYDROCHLORIDE | 1 | Unknown | UNK | 0 | INJECTION | |||||||||
| 125060092 | 12506009 | 5 | C | DEXART | DEXAMETHASONE SODIUM PHOSPHATE | 1 | Unknown | UNK | 0 | INJECTION | |||||||||
| 125060092 | 12506009 | 6 | C | CONTOMIN /00011902/ | CHLORPROMAZINE HYDROCHLORIDE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125060092 | 12506009 | 7 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | 0 | TABLET | |||||||||||
| 125060092 | 12506009 | 8 | C | ZYLORIC | ALLOPURINOL | 1 | Unknown | 0 | TABLET | ||||||||||
| 125060092 | 12506009 | 9 | C | SELBEX | TEPRENONE | 1 | Unknown | 0 | TABLET | ||||||||||
| 125060092 | 12506009 | 10 | C | XARELTO | RIVAROXABAN | 1 | Unknown | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125060092 | 12506009 | 1 | Small cell lung cancer extensive stage |
| 125060092 | 12506009 | 2 | Small cell lung cancer extensive stage |
| 125060092 | 12506009 | 3 | Product used for unknown indication |
| 125060092 | 12506009 | 4 | Product used for unknown indication |
| 125060092 | 12506009 | 5 | Product used for unknown indication |
| 125060092 | 12506009 | 6 | Product used for unknown indication |
| 125060092 | 12506009 | 7 | Product used for unknown indication |
| 125060092 | 12506009 | 8 | Product used for unknown indication |
| 125060092 | 12506009 | 9 | Product used for unknown indication |
| 125060092 | 12506009 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125060092 | 12506009 | OT |
| 125060092 | 12506009 | LT |
| 125060092 | 12506009 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125060092 | 12506009 | Asthenia | |
| 125060092 | 12506009 | Cholecystitis acute | |
| 125060092 | 12506009 | Diverticular perforation | |
| 125060092 | 12506009 | Febrile neutropenia | |
| 125060092 | 12506009 | Gait disturbance |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125060092 | 12506009 | 1 | 20160112 | 0 | ||
| 125060092 | 12506009 | 2 | 20160112 | 20160114 | 0 | |
| 125060092 | 12506009 | 3 | 20160112 | 20160114 | 0 | |
| 125060092 | 12506009 | 4 | 20160112 | 0 |